Publication | Closed Access
Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
82
Citations
0
References
2009
Year
Surgical OncologyAdvanced Lung DiseaseMaintenance PemetrexedMedicineCancer ManagementPathologyPart IiClinical OncologyPulmonary MedicineVersus PlaceboCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchFinal Text
CRA8000 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]